Cargando…
Gene editing and CRISPR in the clinic: current and future perspectives
Genome editing technologies, particularly those based on zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and CRISPR (clustered regularly interspaced short palindromic repeat DNA sequences)/Cas9 are rapidly progressing into clinical trials. Most clinical use of...
Autores principales: | Hirakawa, Matthew P., Krishnakumar, Raga, Timlin, Jerilyn A., Carney, James P., Butler, Kimberly S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146048/ https://www.ncbi.nlm.nih.gov/pubmed/32207531 http://dx.doi.org/10.1042/BSR20200127 |
Ejemplares similares
-
Delivering CRISPR: a review of the challenges and approaches
por: Lino, Christopher A., et al.
Publicado: (2018) -
Editing SOX Genes by CRISPR-Cas: Current Insights and Future Perspectives
por: Dehshahri, Ali, et al.
Publicado: (2021) -
Genetic editing of the virulence gene of Escherichia coli using the CRISPR system
por: Hou, Meijia, et al.
Publicado: (2020) -
Current applications and future perspective of CRISPR/Cas9 gene editing in cancer
por: Wang, Si-Wei, et al.
Publicado: (2022) -
Off-target effects in CRISPR/Cas9 gene editing
por: Guo, Congting, et al.
Publicado: (2023)